Few recent happenings have significantly impacted India-China Trade & Pharma sector is also not being spared. Doklam issue: One of the Borders of dispute between India and China. Doklam (Zhoglam or Droklam or Donglang)...

Indian Pharmaceutical Market Potential: From USD27.57 billion in 2016 there is a potential to reach USD55 billion by 2020. Make in India: “Pharma Vision 2020” End to end drug manufacturing in India is the key here...